TF levels were significantly increased in T2D patients with either 12- or 24- weeks of chiglitazar treatment while only a slight increase in T2D patients with 12- weeks of sitagliptin treatment (Fig. 3C). This evidence concerns the gene TF and type 2 diabetes mellitus.